Manufacturer record

Maxmed Lifesciences Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by Maxmed Lifesciences Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2019 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to Maxmed Lifesciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2019 to Oct 2023

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2019
4
Products affected
Description
Most common failure
Oct 2023
Latest alert

Flagged batches per year

2019 · 42023 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefixime Oral Suspension IP 23CS012Mfg 2023-02 · Exp 2025-01 Water contentWater content RDTL ChandigarhCDSCO lab Oct 2023
Amoxycillin 250 mg and Cloxacillin 250 mg Capsules 21BC012Mfg 2021-05 · Exp 2023-04 DescriptionDescription RDTL GuwahatiState lab Jan 2023
CLOXACILLIN CAPSULES IP 250 mg MBC-18017Mfg 2018-04 · Exp 2020-03 DESCRIPTION AND IDENTIFICATIONDescription CDL ChennaiCDSCO lab Dec 2019
Cefixime Oral Suspension I.P. MCS-17039Mfg 2017-09 · Exp 2019-08 AssayAssay RDTL GuwahatiState lab Aug 2019
Cephalexin Capsules I.P. 500mg. (Staphydex 500mg) MCC-18014Mfg 2018-05 · Exp 2020-04 MisbrandedMisbranded RDTL GuwahatiState lab Mar 2019
Cefixime Tablets I.P. MCT-16123Mfg 2017-03 · Exp 2019-02 WaterWater content CDL KolkataCDSCO lab Jan 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.